Team approach, low-cost interventions lead to major reduction in opioid prescriptions after surgery

A novel team approach founded on a culture change among clinicians and doctor-patient communication successfully reduced post ...
Managed Healthcare Executive

Vertex reports data showing opioid-free recovery with Journavx for most patients after plastic surgery

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...
Fox News

FDA approves opioid-free pain medication with 'no sign of addiction'

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...
Forbes

Uptake Of Novel Non-Opioid Drug Suzetrigine Could Benefit From No Pain Act

This illustration image shows tablets of the opioid painkiller oxycodone. A novel non-opioid treatment for post-surgical pain, suzetrigine, is set to enter the market in 2025. Its uptake could be ...
Health Affairs

The Opioid Crisis: Scaling Up Treatment And Harm Reduction Programs To Reach More People Who Would Benefit

Brendan Saloner ([email protected]), Brown University, Providence, Rhode Island. Pooja Lagisetty, University of Michigan, Ann Arbor, Michigan. Access and scale are two sides of the same coin. Whereas ...